Pricing Log in Create free account

Apnimed, Inc. (APMD) vs Nuvectis Pharma, Inc. (NVCT)

Apnimed, Inc. and Nuvectis Pharma, Inc. are both Biotechnology companies. Apnimed, Inc. and Nuvectis Pharma, Inc. are of similar size ($589.5M and $579.8M). Nuvectis Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Apnimed, Inc. trades at 0.8×. Apnimed, Inc. has the higher net margin (81.6% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Apnimed, Inc. leads on 8 and Nuvectis Pharma, Inc. on 3.

Valuation

Metric APMD NVCT Biotechnology median
P/E 0.76 n/m 10.60
P/S 0.62 n/m 9.40
P/B n/m 4.84 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales (0.18) n/m 9.02
Earnings yield 130.86% (9.08%) (32.88%)
Free cash flow yield (115.77%) (6.57%) (23.13%)

Profitability

Metric APMD NVCT Biotechnology median
Gross margin 94.53% — 68.51%
Operating margin 19.88% 0.00% 0.00%
Net margin 81.56% 0.00% 0.00%
Free cash flow margin (71.50%) 0.00% 0.00%
Return on equity 0.00% (66.98%) (51.96%)
Return on assets 0.00% (57.20%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APMD NVCT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (14.69%) (18.92%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric APMD NVCT Biotechnology median
Debt to equity (0.45) 0.00 0.00
Current ratio 5.19 9.92 4.97
Net debt to EBITDA 0.02 1.15 1.01

Dividend

Metric APMD NVCT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APMD NVCT Biotechnology median
Market cap 589.49m 579.76m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack